Long-Time Horizon Analysis of Plus Therapeutics Inc (PSTV) Stock

Plus Therapeutics Inc [PSTV] stock prices are up 16.38% to $0.37 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PSTV shares have gain 81.04% over the last week, with a monthly amount glided 25.94%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Plus Therapeutics Inc [NASDAQ: PSTV] stock has seen the most recent analyst activity on March 17, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on January 25, 2021, and set its price target to $8. On October 16, 2020, Maxim Group initiated with a Buy rating and assigned a price target of $6 on the stock.

The stock price of Plus Therapeutics Inc [PSTV] has been fluctuating between $0.16 and $2.31 over the past year. Plus Therapeutics Inc [NASDAQ: PSTV] shares were valued at $0.37 at the most recent close of the market.

Analyzing the PSTV fundamentals

The Plus Therapeutics Inc [NASDAQ:PSTV] reported sales of 5.21M for trailing twelve months, representing a drop of -36.85%. Gross Profit Margin for this corporation currently stands at -1.17% with Operating Profit Margin at -11.67%, Pretax Profit Margin comes in at -21.2%, and Net Profit Margin reading is -21.2%. To continue investigating profitability, this company’s Return on Assets is posted at -2.25, Equity is 2.39 and Total Capital is -9.97. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3314 points at the first support level, and at 0.2962 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4104, and for the 2nd resistance point, it is at 0.4542.

Ratios To Look Out For

It’s worth pointing out that Plus Therapeutics Inc [NASDAQ:PSTV]’s Current Ratio is 0.99. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.93. Considering the valuation of this stock, the price to sales ratio is 3.59.

Transactions by insiders

Recent insider trading involved Petersen Greg, Director, that happened on May 15 ’25 when 36666.0 shares were purchased. Director, Hawkins Richard J completed a deal on Sep 13 ’24 to buy 4000.0 shares. Meanwhile, Director Hawkins Richard J bought 6285.0 shares on Sep 12 ’24.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.